ALTRAVAX, INC.
Patent Owner
Stats
- 6 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- May 31, 2016 most recent publication
Details
- 6 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 95 Total Citation Count
- Feb 26, 2003 Earliest Filing
- 0 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9186397 Recombinant dengue virus antigen comprising the capsid protein leader sequence, full-length prM protein, and full-length E proteinMar 11, 14Nov 17, 15[A61K, C07K]
8715694 Recombinant dengue virus antigen comprising the capsid protein leader sequence, full-length prM protein, and full-length E proteinApr 16, 12May 06, 14[A61K]
8168772 Nucleic acids encoding novel chimeric C15/prM/E dengue virus immunogens prepared by DNA shufflingAug 30, 07May 01, 12[C07H, A61K]
8158131 Recombinant dengue virus antigens comprising the C15 signal peptide, full-length PRM protein, and full-length E proteinMar 07, 08Apr 17, 12[A61K]
Expired/Abandoned/Withdrawn Patents
- No Patents to Display
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.